Cargando…

Discovery and Preclinical Characterization of Novel Small Molecule TRK and ROS1 Tyrosine Kinase Inhibitors for the Treatment of Cancer and Inflammation

Receptor tyrosine kinases (RTKs), in response to their growth factor ligands, phosphorylate and activate downstream signals important for physiological development and pathological transformation. Increased expression, activating mutations and rearrangement fusions of RTKs lead to cancer, inflammati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Narayanan, Ramesh, Yepuru, Muralimohan, Coss, Christopher C., Wu, Zhongzhi, Bauler, Matthew N., Barrett, Christina M., Mohler, Michael L., Wang, Yun, Kim, Juhyun, Snyder, Linda M., He, Yali, Levy, Nelson, Miller, Duane D., Dalton, James T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3873281/ https://www.ncbi.nlm.nih.gov/pubmed/24386191 http://dx.doi.org/10.1371/journal.pone.0083380

Ejemplares similares

Selective Androgen Receptor Modulators (SARMs) Negatively Regulate Triple-Negative Breast Cancer Growth and Epithelial:Mesenchymal Stem Cell Signaling
por: Narayanan, Ramesh, et al.
Publicado: (2014)

Selective androgen receptor modulators in preclinical and clinical development
por: Narayanan, Ramesh, et al.
Publicado: (2008)

Discovery of oncogenic ROS1 missense mutations with sensitivity to tyrosine kinase inhibitors
por: Iyer, Sudarshan R, et al.
Publicado: (2023)

An Overview of Next-Generation Androgen Receptor-Targeted Therapeutics in Development for the Treatment of Prostate Cancer
por: Mohler, Michael L., et al.
Publicado: (2021)

On the right TRK: from oncogene discovery to cancer therapeutics
por: Barbacid, M
Publicado: (2019)

Cellular Assays for High-Throughput Screening for Modulators of Trk Receptor Tyrosine Kinases
por: Wang, Jun, et al.
Publicado: (2008)

Mitochondrial ROS potentiates indirect activation of the AIM2 inflammasome
por: Crane, Deborah D., et al.
Publicado: (2014)

Identification of a Novel Series of Potent TrkA Receptor Tyrosine Kinase Inhibitors
por: Raeppel, Stéphane L., et al.
Publicado: (2012)

TRK inhibitors in TRK fusion-positive cancers
por: Drilon, A
Publicado: (2019)

Discovery and Preclinical Work
por: Mochly-Rosen, Daria, et al.
Publicado: (2013)

The neurotrophin receptor, gp75, forms a complex with the receptor tyrosine kinase TrkA
Publicado: (1996)

TrkA receptor ectodomain cleavage generates a tyrosine-phosphorylated cell-associated fragment
Publicado: (1996)

The Receptor Tyrosine Kinase TrkA Is Increased and Targetable in HER2-Positive Breast Cancer
por: Griffin, Nathan, et al.
Publicado: (2020)

Rapid Retrograde Tyrosine Phosphorylation of trkA and Other Proteins in Rat Sympathetic Neurons in Compartmented Cultures
por: Senger, Donna L., et al.
Publicado: (1997)

Regulation of TrkB receptor tyrosine kinase and its internalization by neuronal activity and Ca(2+) influx
por: Du, Jing, et al.
Publicado: (2003)

α(2)-Adrenergic Disruption of β Cell BDNF-TrkB Receptor Tyrosine Kinase Signaling
por: Kalwat, Michael A., et al.
Publicado: (2020)

Immunohistochemical detection of Tyrosine Kinase receptor (TrK) in follicular and plexiform ameloblastoma – A novel study
por: Jisha, George Babu, et al.
Publicado: (2020)

Photosensitive tyrosine analogues unravel site-dependent phosphorylation in TrkA initiated MAPK/ERK signaling
por: Zhao, Shu, et al.
Publicado: (2020)

TrkA Co-Receptors: The Janus Face of TrkA?
por: Trouvilliez, Sarah, et al.
Publicado: (2023)

A Virtual Patient Encounter to Promote Integration in a Preclinical Case-Based Learning Session
por: Bauler, Timothy J., et al.
Publicado: (2023)

Discovery of 5-Phenoxy-2-aminopyridine Derivatives as Potent and Selective Irreversible Inhibitors of Bruton’s Tyrosine Kinase
por: Lee, Eun, et al.
Publicado: (2020)

Design and Nuclear Magnetic Resonance (NMR) Structure Determination of the Second Extracellular Immunoglobulin Tyrosine Kinase A (TrkAIg2) Domain Construct for Binding Site Elucidation in Drug Discovery
por: Shoemark, Debbie K., et al.
Publicado: (2014)

A Cross-Talk between TrkB and Ret Tyrosine Kinases Receptors Mediates Neuroblastoma Cells Differentiation
por: Esposito, Carla Lucia, et al.
Publicado: (2008)

The neurotrophic tyrosine kinase receptor TrkA and its ligand NGF are increased in squamous cell carcinomas of the lung
por: Gao, Fangfang, et al.
Publicado: (2018)

Nerve growth factor and its receptor tyrosine kinase TrkA are overexpressed in cervical squamous cell carcinoma
por: Faulkner, Sam, et al.
Publicado: (2020)

Selective activation and down‐regulation of Trk receptors by neurotrophins in human neurons co‐expressing TrkB and TrkC
por: Ateaque, Sarah, et al.
Publicado: (2022)

NVL-520 Is a Selective, TRK-Sparing, and Brain-Penetrant Inhibitor of ROS1 Fusions and Secondary Resistance Mutations
por: Drilon, Alexander, et al.
Publicado: (2023)

The FERM and PDZ Domain-Containing Protein Tyrosine Phosphatases, PTPN4 and PTPN3, Are Both Dispensable for T Cell Receptor Signal Transduction
por: Bauler, Timothy J., et al.
Publicado: (2008)

Discovery and preclinical development of new antibiotics
por: Hughes, Diarmaid, et al.
Publicado: (2014)

Association between Single-Nucleotide Polymorphisms of the Tyrosine Kinase Receptor B (TrkB) and Post-Stroke Depression in China
por: Zhou, Zhiming, et al.
Publicado: (2015)

Retraction: A Cross-Talk between TrkB and Ret Tyrosine Kinases Receptors Mediates Neuroblastoma Cells Differentiation
Publicado: (2022)

Activation of tyrosine phosphatase PTP1B in pyramidal neurons impairs endocannabinoid signaling by tyrosine receptor kinase trkB and causes schizophrenia-like behaviors in mice
por: Qin, Zhaohong, et al.
Publicado: (2020)

Basket trial of TRK inhibitors demonstrates efficacy in TRK fusion-positive cancers
por: Chen, Yu, et al.
Publicado: (2018)

Acquired cancer tyrosine kinase inhibitor resistance: ROS as critical determinants
por: Bekeschus, Sander
Publicado: (2021)

Two Trk/Ktr/HKT-type potassium transporters, TrkG and TrkH, perform distinct functions in Escherichia coli K-12
por: Tanudjaja, Ellen, et al.
Publicado: (2022)

Combinatorial Assembly of Small Molecules into Bivalent Antagonists of TrkC or TrkA Receptors
por: Brahimi, Fouad, et al.
Publicado: (2014)

Detection of Tumor NTRK Gene Fusions to Identify Patients Who May Benefit from Tyrosine Kinase (TRK) Inhibitor Therapy
por: Hsiao, Susan J., et al.
Publicado: (2019)

Discovery of a novel ALK/ROS1/FAK inhibitor, APG-2449, in preclinical non-small cell lung cancer and ovarian cancer models
por: Fang, Douglas D., et al.
Publicado: (2022)

Discovery and Preclinical Development of Antigiardiasis Fumagillol Derivatives
por: Padia, Janak, et al.
Publicado: (2020)

Literature-based discovery of diabetes- and ROS-related targets
por: Hur, Junguk, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_ot7jvj2u17fhare5cmadosvehu